Rivastigmine for Intensive Care Unit (ICU) Delirium

This study has been terminated.
(The study is prematurely terminated due to a safety issue)
Sponsor:
Collaborators:
ZonMw: The Netherlands Organisation for Health Research and Development
Novartis
Hersenstichting
Information provided by:
UMC Utrecht
ClinicalTrials.gov Identifier:
NCT00704301
First received: June 20, 2008
Last updated: August 12, 2010
Last verified: October 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: May 2010
  Primary Completion Date: April 2010 (Final data collection date for primary outcome measure)
No publications provided by UMC Utrecht

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):